Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women

Clinical Infectious Diseases

Volumn 53, Issue 9, 2011, Pages 885-892

  Halperin, B A ^a,b   Morris, A ^a   MacKinnon Cameron, D ^a   Mutch, J ^a   Langley, J M ^a,b,c,d   McNeil, S A ^a,b,d,e   MacDougall, D ^a   Halperin, S A ^a,b,d  

^a Canadian Center for Vaccinology Dalhousie University Halifax   (Canada)

^b Department of Pediatrics ^*  (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d IWK HEALTH CENTRE   (Canada)

^e Capital Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGE; ANTIBODY RESPONSE; ARTICLE; BREAST MILK; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; NORMAL HUMAN; PRIORITY JOURNAL; PUERPERIUM; VACCINATION;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BLOOD; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MILK, HUMAN; POSTPARTUM PERIOD; YOUNG ADULT;

EID: 80054076949     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir538     Document Type: Article

References (44)

1. Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J 2003; 22:628-34. (Pubitemid 36900210)
2. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23:985-9. (Pubitemid 40824285)
3. Halperin SA, Wang EE, Law B, et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program-Active (IMPACT). Clin Infect Dis 1999; 28:238-43.
4. Mikelova LK, Halperin SA, Scheifele D, Smith D, Ford-Jones E, et al. Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada. J Pediatr 2003; 143:576-81. (Pubitemid 37452782)
5. Wendelboe AM, Njamkepo E, Bourillon A, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007; 26: 293-9. (Pubitemid 46596651)
6. Halperin SA. Canadian experience with implementation of an acellular pertussis vaccine booster-dose program in adolescents: Implications for the United States. Pediatr Infect Dis J 2005; 24(6 Suppl):S141-S146. (Pubitemid 40840111)
7. Guris D, Strebel P, Bardenheir B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999; 28:230-7.
8. De Serres G, Shadmani R, Duvall B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000; 182:174-9. (Pubitemid 30497802)
9. Skowronski DM, De Serres G,MacDonald D, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis 2002; 185:1448-53. (Pubitemid 34507967)
10. Centers for Disease Control and Prevention. Pertussis-United States, 2001-2003. MMWR Morb Mortal Wkly Rep 2005; 54:1283-6.
11. Baron S, Njamkepo E, Grimple E, et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Infect Dis J 1998; 17:412-8. (Pubitemid 28232866)
12. He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA 1998; 280:635-7. (Pubitemid 28502641)
13. Ranganathan S, Tasker R, Booy R, Habibi P, Nadel S, Britto J. Pertussis is increasing in unimmunized infants; is a change in policy needed? Arch Dis Child 1999; 80:297-9. (Pubitemid 29109427)
14. Elliott E, McIntyre P, Ridley G, et al. National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatr Infect Dis J 2004; 23:246-52. (Pubitemid 38332651)
15. McIntyre P, Wood N. Pertussis in early infancy: disease burden and preventive strategies. Curr Opin Infect Dis 2009; 22:215-23.
16. Mooi FR, de Greef SC. The case for maternal vaccination against pertussis. Lancet Infect Dis 2007; 7:614-24. (Pubitemid 47268217)
17. Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine 2004; 22:3154-65. (Pubitemid 39037219)
18. Halperin S. Serologic and molecular tools for diagnosing Bordetella pertussis. In: Detrick B, Hamilton R, Folds J, eds. Manual of Molecular and Clinical Laboratory Immunology. 7th ed. Washington, DC: American Society for Microbiology Press; 2006. p.540-6.
19. Halperin SA, Smith B, Russell M, et al. Adult formulation of a fivecomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults. Pediatr Infect Dis J 2000; 19:276-83. (Pubitemid 30213063)
20. Halperin SA, Smith B, Russell M, et al. An adult formulation of a fivecomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine 2000; 18:1312-9. (Pubitemid 30017842)
21. Broder KR, Cortese MM, Iskander JK, et al. Preventing tetanus, diphtheria, and pertussis among adolescents: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1-34.
22. Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005; 24(5 Suppl):S10-S18. (Pubitemid 40676531)
23. Ulloa-Gutierrez R, Avila-Aguero ML. Pertussis in Latin America: current situation and future vaccination challenges. Expert Rev Vaccines 2008; 7:1569-80.
24. Roehr B. Whooping cough outbreak hits several US states. BMJ 2010; 341:c4627.
25. Lawrence R. Whooping cough on the rise in Saskatchewan. Moose Jaw Times Herald 30 September 2010. Available at: http://www.mjtimes. sk.ca/News/Local/ 2010-09-30/article-1809662/Whooping-Cough-on-therise-in-Saskatchewan/1. Accessed 29 December 2010.
26. Van Savage J, Decker MD, Edwards KM, Sell SH, Karzon DT. Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis 1990; 161:487-92. (Pubitemid 20107950)
27. Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 2004; 190:335-40. (Pubitemid 38951975)
28. Foxwell AR, McIntyre P, Quinn H, Roper K, Clements MS. Estimated impact of first vaccine dose at 6 versus 8 weeks in Australia. Pediatr Infect Dis J 2011; 30:161-3.
29. Shinall MC, Peters TR, Zhu Y, Chen Q, Poehling KA. Potential impact of acceleration of the pertussis vaccine primary series for infants. Pediatrics 2008; 122:1021-6.
30. Halasa NB, O'Shea A, Shi JR, LaFleur BJ, Edwards KM. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr 2008; 153:327-32.
31. Wood N, McIntyre P, Marshall H, Roberton D. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J 2010; 29:209-15.
32. Knuf M, Schmitt HJ, Wolter J, et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr 2008; 152:655-60.
33. Coudeville L, van Rie A, Andre P. Adult pertussis vaccination strategies and their impact on pertussis in the United States: Evaluation of routine and targeted (cocoon) strategies. Epidemiol Infect 2008; 136: 604-20. (Pubitemid 351472170)
34. Kandola K, Lea A, White W, Santos M. A comparison of pertussis rates in the Northwest Territories: pre-and post-acellular pertussis vaccine introduction in children and adolescents. Can J Infect Dis Med Microbiol 2005; 16:271-4. (Pubitemid 41719718)
35. Oda M, Izumiya K, Sato Y, Hirayama M. Transplacental and transcolostral immunity to pertussis in a mouse model using acellular pertussis vaccine. J Infect Dis 1983; 148:138-45. (Pubitemid 13039323)
36. Elahi S, Buchanan RM, Babiuk LA, Gerdts V. Maternal immunity provides protection against pertussis in newborn piglets. Infect Immun 2006; 74:2619-27. (Pubitemid 43672970)
37. Pisacane A, Graziano L, Zona G, et al. Breast feeding and acute lower respiratory infection. Acta Paediatr 1994; 83:714-8. (Pubitemid 24248821)
38. National Advisory Committee on Immunization (NACI). Statement on the prevention of pertussis in adolescents and adults. Can Commun Dis Rep 2003; 29:1-9.
39. Safety and immunogenicity of Tdap vaccine in healthy pregnant women, safety in their neonates, and effect of maternal immunization on infant immune responses to dTap Vaccine. Available at: www.clinicaltrials. gov. Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). ClinicalTrials.gov Identifier: NCT00707148. Accessed 29 December 2010.
40. Immunization of women with diphtheria and tetanus toxoids combined with acellular pertussis (Tdap) during the mid third trimester of pregnancy: An evaluation of the potential for immunological protection for the neonate. Available at: www.clinicaltrials.gov. (Sponsor: Dalhousie University; collaborators: IWK Health Centre, Sanofi Pasteur.). ClinicalTrials.gov Identifier: NCT00553228. Accessed 29 December 2010.
41. Cherry JD, Gornbein J, Heininger U, Stehr K. Search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998; 16:1901-6. (Pubitemid 28473933)
42. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of antipertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998; 16:1907-16. (Pubitemid 28473934)
43. Hewlett EL, Halperin SA. Serological correlates of immunity to Bordetella pertussis. Vaccine 1998; 16:1899-900. (Pubitemid 28473932)
44. Meyer CU, Zepp F, Decker M, et al. Cellular immunity in adolescents and adults following acellular pertussis vaccine administration. Clin Vaccine Immunol 2007; 14:288-92. (Pubitemid 46570286)